BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2002
View Archived Issues
Potential use of efalizumab in the treatment of T-cell-mediated diseases
Read More
The ETA receptor antagonist BQ-123 prevents endothelial dysfunction induced by mental stress
Read More
Adjuvant QS-21 enhances immunogenicity of malaria peptide vaccine
Read More
Transkaryotic Therapies announces second quarter highlights
Read More
Alizyme offers six-month progress report
Read More
Neurodex enters phase II trial in diabetic neuropathic pain
Read More
Biopure submits Hemopure BLA
Read More
Xyotax enters phase II trial in breast cancer
Read More
Initiation of phase II/III trial of CEP-1347 in early-stage Parkinson's disease
Read More
MT-400 development program agreed with FDA and MCA
Read More
MTC-DOX designated orphan drug in E.U.
Read More
Novel glucokinase activators described in Roche patent
Read More
Merck Frosst presents caspase-3 inhibitors with potential in ischemic disorders
Read More
Novel topoisomerase I inhibitors in Advanced Life Sciences pipeline
Read More
Akzo Nobel researchers identify new androgenic/progestagenic compounds
Read More
Bayer claims novel beta3-adrenoceptor agonists for diabetes, obesity, etc.
Read More
New quinolones and quinolizinones in early development at P&G
Read More
